Device Trial Radar · NCT06136312
Clinical Investigation of the Multi4 System
Last checked: Nov 20, 2026Latest source record: Apr 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Dec 1, 2023
Primary completion
Apr 2, 2025
Study completion Apr 2, 2025
Sponsor
- Lead sponsor
- Multi4 Medical AbNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Key2Compliance
- First posted
- Nov 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients with Suspected Recurrent Bladder Cancer Lesions
Conditions
- Bladder Cancer
Interventions
Multi4Device
TURBT procedure performed with the Multi4 instrument in local anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluable biopsiesTime frame: At procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sahlgrenska University Hospital
Gothenburg, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.